EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

HCP5 Derived Novel Microprotein Triggers Progression of Gastric Cancer through Regulating Ferroptosis

Qiuhui Li, Guoqing Guo, Yuli Chen, Lu Lu, Hanyang Li, Zihan Zhou, Jiahao Guo, Xiongkang Gan, Yanming Hu, Qiunuo Li, Ming Sun iD, Xianghua Liu

Advanced Science · 2024-12 · 11 (46)

DOI: 10.1002/advs.202407012 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 24.10.2024. Verfasst von Qiuhui Li und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Nanjing Medical University, Nanjing, 211166, China. Hauptthemen laut MEDLINE: Stomach Neoplasms, RNA, Long Noncoding, Ferroptosis, Disease Progression. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The context of long noncoding RNAs (lncRNAs) contains many unannotated open reading frames (ORFs). These ORFs potentially encode novel proteins or peptides with crucial roles in various human cancers, yet the translational potential of these lncRNAs and the functions of the protein products remain largely unexplored, especially in gastric cancer (GC). In this study, a comprehensive analysis is performed and identified a GC associated lncRNA known as HCP5, which contains a non‐canonical ORF. Further analysis showed that HCP5‐132aa, a microprotein encoded by HCP5 harboring this ORF, is highly expressed in GC cells and tissues, and can promote the proliferation of GC cells by inhibiting ferroptosis. Mechanistically, HCP5‐132aa enhances the interaction between YBX1 and ELAVL1, facilitates recognition of YBX1 at the m 5 C site in the 3′UTR of SLC7A11 and G6PD mRNA, and preserves their stability via ELAVL1. By employing a Cas9/sgRNA delivery system with AAV in vivo, effectively knocked out the HCP5‐132aa and inhibition of tumor growth in a patient‐derived xenograft model are achieved. These findings demonstrate that the novel protein HCP5‐132aa, derived from lncRNA HCP5, mediates the repression of ferroptosis, thereby driving the progression of GC and identifying a new potential therapeutic target for its treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsRNA, Long NoncodingFerroptosisDisease ProgressionHumansMiceAnimalsCell Line, TumorDisease Models, AnimalCell ProliferationGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

HCP5‐132aaYBX1ferroptosisgastric cancerm5C modification

Substanzen

RNA, Long NoncodingHCP5 long noncoding RNA, human

Autor:innen und Institutionen

  • Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Nanjing Medical University, Nanjing, 211166, China.
  • Suzhou Cancer Center Core Laboratory, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, Nanjing Medical University, Suzhou, 215001, China.
  • The First Clinical Medical College, Nanjing Medical University, Nanjing, 211166, China.
  • Department of Cardiovascular Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China.

ORCID-Profile: Ming Sun

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Jiangsu Province
  • The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School
  • Suzhou GuSu Health Talent Research Project
  • The College Students' Innovative Entrepreneurial Trianing Plan Program of China

Zitieren

APA

Li, Q., Guo, G., Chen, Y., Lu, L., Li, H., Zhou, Z., Guo, J., Gan, X., Hu, Y., Li, Q., Sun, M., & Liu, X. (2024). HCP5 Derived Novel Microprotein Triggers Progression of Gastric Cancer through Regulating Ferroptosis. Advanced Science, 11(46). https://doi.org/10.1002/advs.202407012

Vancouver

Li Q, Guo G, Chen Y, Lu L, Li H, Zhou Z, et al. HCP5 Derived Novel Microprotein Triggers Progression of Gastric Cancer through Regulating Ferroptosis. Advanced Science. 2024;11(46). doi:10.1002/advs.202407012

BibTeX
@article{Li2024,
  author = {Li, Qiuhui and Guo, Guoqing and Chen, Yuli and Lu, Lu and Li, Hanyang and Zhou, Zihan and Guo, Jiahao and Gan, Xiongkang and Hu, Yanming and Li, Qiunuo and Sun, Ming and Liu, Xianghua},
  title = {HCP5 Derived Novel Microprotein Triggers Progression of Gastric Cancer through Regulating Ferroptosis},
  journal = {Advanced Science},
  year = {2024},
  volume = {11},
  number = {46},
  doi = {10.1002/advs.202407012}
}
Kostenlos starten →